In this study, we identified SNHG12, a lncRNA downregulated in GCs of PCOS patients, as a molecule that competitively disrupts the interaction between HMGB1 and the PTEN promoter, thereby regulating the glycolytic pathway in GCs. Here, PTEN is linked to polycystic ovary syndrome.